Tutorials
DexCom Inc logo

DexCom Inc

$ 91.26 +2.17 (+2.44%) 02:32 PM EST
On watch
P/E:
189.73
P/B:
15.88
Market Cap:
$ 35.83B
Enterprise V:
$ 34.02B
Volume:
2.19M
Avg Vol (2M):
2.94M
Also Trade In:
Volume:
2.19M
Market Cap $:
35.83B
PE Ratio:
189.73
Avg Vol (2-Month):
2.94M
Enterprise Value $:
34.02B
PB Ratio:
15.88
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

DexCom Inc
NAICS : 325413 SIC : 5047
6340 Sequence Drive, San Diego, CA, USA, 92121
Description
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Name Current Vs Industry Vs History
Cash-To-Debt 1.29
Equity-to-Asset 0.43
Debt-to-Equity 0.95
Debt-to-EBITDA 5.52
Interest Coverage 3.82
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 8.52
Distress
Grey
Safe
Beneish M-Score -2.5
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 65.58
9-Day RSI 65.17
14-Day RSI 62.87
6-1 Month Momentum % -25.34
12-1 Month Momentum % -40.1

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.72
Quick Ratio 4.3
Cash Ratio 3.41
Days Inventory 137.7
Days Sales Outstanding 71.87
Days Payable 75.84

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.5

Financials (Next Earnings Date:2022-10-28 Est.)

DXCM's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:DXCM

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2,673.4
EPS (TTM) ($) 0.481
Beta 1.02
Volatility % 51.73
14-Day RSI 62.87
14-Day ATR ($) 3.841398
20-Day SMA ($) 82.86875
12-1 Month Momentum % -40.1
52-Week Range ($) 66.8925 - 164.86295
Shares Outstanding (Mil) 392.58

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

DexCom Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More